The Dexcom logo is seen on a smartphone screen and in the background.
Pavlo Gonchar | SOPA Images | Lightrocket | Getty Images
Shares of Dexcom tumbled more than 33% in after-hours trading Thursday after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance.
Here’s how the company did:
- Earnings per share: 43 cents adjusted vs. 39 cents expected by LSEG
- Revenue: $1 billion vs. $1.04 billion expected by LSEG
Dexcom’s revenue increased 15% from $871.3 million a year earlier, according to a release.
This is breaking news. Please refresh for updates.